API australian pharmaceutical industries limited

News: API Australia's Wesfarmers buys 19% API shares to block Sigma's proposed offer

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Oct 7 (Reuters) - Australia's Wesfarmers Ltd (WES) said on Thursday it has bought 19.3% of the shares of Australian Pharmaceutical Industries Ltd (API) , as part of a deal with API's top shareholder in July to block rival Sigma Healthcare Ltd's (SIG) proposed offer.

    Sigma made an offer for API last month, valuing the pharmaceutical company at A$773.5 million ($562.72 million).

    ($1 = 1.3746 Australian dollars)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.